NASDAQ:NTLA - Intellia Therapeutics SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$16.86 +0.15 (+0.90 %)
(As of 03/20/2019 09:24 AM ET)
Previous Close$16.71
Today's Range$16.35 - $16.97
52-Week Range$11.03 - $32.95
Volume467,884 shs
Average Volume768,616 shs
Market Capitalization$762.41 million
P/E Ratio-8.52
Dividend YieldN/A
Beta2.92

SEC Filings

Intellia Therapeutics (NASDAQ:NTLA) SEC Filings

DateFilerForm TypeView
03/12/2019
3:38 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/11/2019
2:15 PM
Intellia Therapeutics (Filer)
Form CT ORDER
View Filing
03/05/2019
3:36 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/27/2019
7:40 AM
Intellia Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
02/27/2019
7:37 AM
Intellia Therapeutics (Filer)
Form POS AM
View Filing
02/27/2019
7:23 AM
Intellia Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/27/2019
6:58 AM
Intellia Therapeutics (Filer)
Form POSASR
View Filing
02/27/2019
5:52 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2019
3:02 PM
Intellia Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
02/11/2019
2:15 PM
Intellia Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
View Filing
02/08/2019
5:02 AM
Atlas Venture Fund IX, L.P. (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
View Filing
01/24/2019
4:31 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/24/2019
4:29 PM
Cohen Fred E (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
01/24/2019
6:30 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/16/2019
4:29 PM
Caribou Biosciences, Inc. (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
View Filing
01/07/2019
7:48 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/20/2018
3:25 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/20/2018
3:23 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/20/2018
3:21 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/20/2018
3:16 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/20/2018
3:15 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4/A
View Filing
12/06/2018
6:45 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/01/2018
5:37 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/31/2018
4:58 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/31/2018
4:57 PM
GOODMAN JESSE (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
10/31/2018
8:01 AM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
10/31/2018
6:47 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/29/2018
7:37 PM
Goddard Glenn (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
10/29/2018
4:10 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/12/2018
4:29 PM
Intellia Therapeutics (Filer)
Form S-3ASR
View Filing
08/10/2018
3:44 PM
HAYES JOHN T. (Reporting)
Intellia Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
08/01/2018
6:46 AM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/01/2018
6:30 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/20/2018
3:31 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/18/2018
7:40 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:06 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/20/2018
11:03 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/21/2018
3:15 PM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/21/2018
11:59 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/21/2018
11:56 AM
Intellia Therapeutics (Issuer)
KARSEN PERRY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/21/2018
11:54 AM
DORSA CAROLINE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/21/2018
11:51 AM
Intellia Therapeutics (Issuer)
Verwiel Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/17/2018
9:47 AM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/15/2018
7:43 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/02/2018
3:35 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/01/2018
6:46 AM
Intellia Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/01/2018
6:30 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/01/2018
6:15 AM
Intellia Therapeutics (Filer)
Form 10-K/A
View Filing
04/27/2018
3:06 PM
Intellia Therapeutics (Issuer)
SCHIERMEIER ANDREW (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
04/17/2018
6:30 AM
Intellia Therapeutics (Filer)
Form DEF 14A
View Filing
04/17/2018
6:15 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/30/2018
9:20 AM
Bell Graeme (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/26/2018
4:12 PM
DORSA CAROLINE (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/23/2018
4:29 PM
Intellia Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/23/2018
4:27 PM
Intellia Therapeutics (Subject)
Novartis Institutes for BioMedical Research, Inc. (Filed by)
Form SC 13D/A
View Filing
03/22/2018
12:43 PM
FORMELA JEAN FRANCOIS (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2018
7:04 AM
Intellia Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/14/2018
6:40 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/16/2018
12:25 PM
Intellia Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
View Filing
02/06/2018
3:07 PM
Caribou Biosciences, Inc. (Filed by)
Intellia Therapeutics (Subject)
Form SC 13G/A
View Filing
01/30/2018
4:28 PM
Caribou Biosciences, Inc. (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2018
4:24 PM
Intellia Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13D/A
View Filing
01/29/2018
2:32 PM
Intellia Therapeutics (Issuer)
LEONARD JOHN M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2018
2:31 PM
Bell Graeme (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2018
2:30 PM
Intellia Therapeutics (Issuer)
Rivera Jose E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/18/2017
6:46 AM
Intellia Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/14/2017
3:07 PM
Bermingham Nessan (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2017
3:06 PM
Bell Graeme (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2017
11:29 AM
Intellia Therapeutics (Subject)
Novartis Institutes for BioMedical Research, Inc. (Filed by)
Form SC 13D/A
View Filing
12/14/2017
11:19 AM
Intellia Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/08/2017
4:27 PM
Bermingham Nessan (Reporting)
Intellia Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel